The United States is on the brink of an arthritis epidemic. By the year 2020, arthritis is likely to affect 1 in 5 Amer-icans, according to estimates from both the Arthritis Foundation and the Centers for Disease Control and Prevention. In addition, the nation is facing a crisis of awareness.
Last year, a survey conducted by the Arthritis Foundation revealed that 53% of the respondents had some arthritis symptoms, yet many were unaware of the significance. Also, the survey found that 67% of the respondents were at risk for arthritis, but 52% did not know it. More than 50% said that they had no plans to see a physician about the health of their joints.
Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.
Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?
Clinical features with downloadable PDFs